Back to Search
UCHENNA ILOEJE, MD
MD
Internal Medicine Physician
NPI: 1770566754Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
034119(CT)
Research & Publications (19)
Risk and predictors of mortality associated with chronic hepatitis B infection.
PMID 17678844·Clin Gastroenterol Hepatol·2007
4-observational
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
PMID 16530509·Gastroenterology·2006
8-other
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients.
PMID 15670251·HIV Med·2005
8-other
Hepatitis B virus DNA levels and outcomes in chronic hepatitis B.
PMID 19399801·Hepatology·2009
8-other
Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm.
PMID 18088242·J Viral Hepat·2008
8-other
Cost-effectiveness analysis of entecavir versus lamivudine in the first-line treatment of Australian patients with chronic hepatitis B.
PMID 19382822·Appl Health Econ Health Policy·2008
4-observational
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
PMID 18695135·J Natl Cancer Inst·2008
8-other
Economic implications of entecavir treatment in suppressing viral replication in chronic hepatitis B (CHB) patients in China from a perspective of the Chinese Social Security program.
PMID 18387054·Value Health·2008
8-other
Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection.
PMID 17526021·Hepatology·2007
8-other
Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B.
PMID 17960954·Pharmacoeconomics·2007
2-rct
Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study.
PMID 16817842·Am J Gastroenterol·2006
8-other
Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort.
PMID 16494629·HIV Med·2006
8-other
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
PMID 16391218·JAMA·2006
8-other
Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV-infected patients: a retrospective cohort study.
PMID 15807713·HIV Med·2005
8-other
Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS.
PMID 15705191·Lipids Health Dis·2005
8-other
Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort study.
PMID 15659459·Int J Epidemiol·2005
8-other
Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review.
PMID 13130409·Clin Infect Dis·2003
1-meta
Increased use of lipid-lowering therapy in patients receiving human immunodeficiency virus protease inhibitors.
PMID 12888129·Am J Cardiol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 ABRAHMS BLVD
WEST HARTFORD, CT 06117 - Phone
- (860) 523-3800
Quick Facts
- NPI
- 1770566754
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile